Navigation Links
New Daily Disposable Multifocal Contact Lenses from CooperVision Offer Comfort, Performance, Health, and Convenience to Fit Your Life
Date:5/14/2012

ROCHESTER, N.Y., May 14, 2012 /PRNewswire/ -- More than one billion people worldwide have a vision condition called presbyopia(1), which is a natural decrease in the ability of the lens in the eye to change its shape to focus on close objects. We've all seen others struggle with trying to read menus and newspapers. Maybe it has even happened to you.

To combat this change in vision, which often begins around age 40, many people rely on contact lenses.  However, currently the choices for lenses that are both multifocal and daily disposable are very limited. Presbyopes have had to choose between vision performance and convenience, but that is no longer the case. For these people, things are looking up. 

CooperVision today announced the launch of Proclear® 1 day multifocal daily disposable contact lenses for the growing population of presbyopes looking for a convenient, comfortable, and healthier lens to wear full time, occasionally, or to complement progressive spectacles or reading glasses.

"When it comes to your vision or the way you live your life, we don't think anyone should have to compromise," said Dennis Murphy, executive vice president, global sales and marketing, CooperVision. "With Proclear 1 day multifocal lenses, vision is clear near, far, and in-between, without the need for spectacles."

Comfort and Performance

Proclear is the only lens material cleared by the U.S. Food and Drug Administration for the claim that it: "May provide improved comfort for those who experience dryness or mild discomfort during lens wear." This is especially important for presbyopes who often find that age-related dryness is an issue and deterrent for wearing contact lenses. Proclear also offers natural biocompatibility, meaning that the lenses are made to imitate the cells of the human eye.

A recent CooperVision-sponsored study compared the vision performance of Proclear 1 day multifocal lenses with a market-leading multifocal lens. Among patients with ADDs of +1.25 to +2.50, Proclear 1 day multifocal lenses scored equivalent for near vision and equivalent or better for intermediate and distance vision after one hour of wear. In the same study, Proclear 1 day multifocal lenses were preferred for vision among patients with ADDs of +2.00 to +2.50 after one hour of wear.

Convenience and Health

With daily disposable lenses, the cost and hassle of a lens care solution is eliminated. And because the lenses are replaced each day, they are one of the healthiest modalities available. Proclear 1 day multifocal lenses provide patients with the freedom to maintain an active and social lifestyle, allowing the wearer to decide whether to wear the lenses all day, part of the day, or reserve them for special situations. Plus, as your prescription changes, your eye care practitioner can easily adjust it, which means minimal disturbance to your vision, shorter appointments, and fewer follow-ups.

"With Proclear 1 day multifocal lenses, people get fresh lenses every day," added Murphy."For many, this also represents a fresh start to their contact wearing experience."

CooperVision offers a broad portfolio of multifocal lenses on the market. The latest lens, Proclear 1 day multifocal, is manufactured with the company's PC Technology™, a unique lens material that attracts and maintains moisture, thus reducing dryness.

The lens will be launched initially in the U.S., Canada, Australia, New Zealand, and a number of European countries. For more information on CooperVision's comprehensive line of multifocal contact lenses, visit www.coopervision.com/multifocal.

About CooperVision

CooperVision, a unit of The Cooper Companies, Inc. (NYSE: COO), is one of the world's leading manufacturers of soft contact lenses. Dedicated to continually bringing a refreshing perspective to the contact lens experience for practitioners and patients, CooperVision specializes in lenses for astigmatism, presbyopia, and ocular dryness. The company routinely collaborates with eye care professionals in the research and development of relevant products. CooperVision manufactures a full array of monthly, two-week, and daily disposable contact lenses featuring advanced materials and optics. For more information, visit www.coopervision.com.

(1) Holden BA, Fricke TR, Ho SM, et al. Global vision impairment due to uncorrected presbyopia. Archives of Ophthalmology. 2008; 126(12): 1731-1739.


'/>"/>
SOURCE CooperVision
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Findings of Daily Consumption of Soy Isoflavones and Cacao-Flavonoids in Diabetes Type 2 Patients
2. OncoSec Medical Featured in Medical Device Daily
3. FDA Advisory Committee Recommends US Approval of Novartis Once-daily Bronchodilator QAB149 for COPD
4. Positive Top-line Results From Phase III GETGOAL Clinical Trial Using Once-Daily Lixisenatide in Combination With Basal Insulin
5. Neupro® (Rotigotine Transdermal System) Significantly Improved Wellbeing and Daily Activities Impaired Due to Limb Pain Associated With Restless Legs Syndrome
6. PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
7. Patton Medical Devices Partners With Unomedical to Develop and Market the i-port Advance(TM) Injection Port for People Taking Multiple Daily Injections
8. Study Published in Child and Adolescent Psychiatry and Mental Health Demonstrated Once-Daily Vyvanse(R) (lisdexamfetamine dimesylate) CII Provided Significant Improvement of ADHD Symptoms for Children at 13 Hours After Administration
9. Three Rivers Announces Positive Results from Phase 3 DIRECT Trial of Once-Daily INFERGEN(R) with Ribavirin in Hepatitis C Virus Treatment Failures
10. Novel Once Daily Anti-Epileptic Zebinix(R) Approved in the European Union
11. BioMarin Receives Notice of Allowance for Once Daily Dosing Patent for Kuvan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 23, 2016  The Prostate Cancer Foundation (PCF) is pleased to ... faster cures for prostate cancer. Members of the Class of 2016 were selected ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... NC (PRWEB) , ... June 23, 2016 , ... In ... University Hospital in Denmark detail how a patient who developed lymphedema after being treated ... tissue. The results could change the paradigm for dealing with this debilitating, frequent side ...
(Date:6/23/2016)... ... June 23, 2016 , ... ... at the Pennsylvania Convention Center and will showcase its product’s latest features from ... also be presenting a scientific poster on Disrupting Clinical Trials in The Cloud ...
Breaking Biology Technology:
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... June 3, 2016 ... Nepal hat ein ... hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung und ... der Produktion und Implementierung von Identitätsmanagementlösungen. Zahlreiche ... im Januar teilgenommen, aber Decatur wurde als ...
(Date:5/24/2016)... Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the medical ... premium product recently added to the range of products distributed by Ampronix. ... ... ... Ampronix News ...
Breaking Biology News(10 mins):